Videos

Which came first: symptoms or diagnosis?

We're excited to preview our new upcoming partnership with the Psych NP Network at Real Psychiatry!

How has bipolar treatment changed over the past 40 years? The celebration of 40 years of Psychiatric Times continues at the Real Psychiatry conference.

Joseph Volpicelli MD, PhD, reflects on 40 years of advancements in addiction treatment, from overcoming stigma to integrating evidence-based therapies like naltrexone.

The top 3 issues in treating bipolar disorder are...

We've upgraded our phones and computers... is it time to upgrade our psychiatric medications?

Carmen Kosicek, MSN, PMHNP-BC, is ready to teach nurse practitioners and advanced providers in a fun, innovative way at Real Psychiatry in Scottsdale, AZ.

Want to stay in the loop on the latest novel neuroplastogen for major depressive disorder, DLX-001? Check out this update.

"In my poem, says another, I can forget I am forgotten. Now I understand being misunderstood..."

A patient discusses their struggles coming to terms with a posttraumatic stress disorder (PTSD) diagnosis after multiple traumatic events, detailing their initial resistance to seeking help, the breakthrough moments in therapy that led to acceptance, and their ongoing journey of healing through various treatment approaches.

Chris Schenewerk, MD, shares how his battle with alcohol addiction transformed his understanding of addiction treatment.

While current antidepressants are associated with improved lives for patients, significant challenges arise. Do we need a new class of antidepressants to address these issues?

How can personalized care, addressing comorbidities, and focusing on gradual improvement help increase treatment success for alcohol use disorder?

What can we learn from nonverbal cues?

Is there a way to separate the neuroplasticity and therapeutic effects from the hallucinatory and dissociative effects of traditional psychedelics?

Melanie Barrett, MD; Anita Clayton, MD, and Carmen Kosicek, MSN, PMHNP-BC, discuss how effective screening tools like the Edinburgh Postnatal Depression Scale (EPDS) and PHQ-9, combined with comprehensive clinical assessments, are crucial for accurately identifying postpartum depression during routine prenatal and postnatal visits.

DLX-001 is a novel neuroplastogen under development for the treatment of major depressive disorder. Learn more about the latest phase 1 data here.

Panelists discuss how to diagnose postpartum depression (PPD) promptly using tools such as standardized screening questionnaires, especially in busy or resource-limited settings, and explore strategies to enhance PPD screening in underserved and minority populations in which symptoms may be underreported, while also considering the role of the case study patient’s family history in identifying her PPD symptoms.

Panelists discuss how specific symptoms, such as persistent sadness, emotional numbness, and disconnection from the baby, help distinguish postpartum depression (PPD) from postpartum anxiety or “baby blues,” and how to approach assessing a patient such as Emily, who is experiencing these symptoms for the first time despite previous pregnancies.

"Tell yourself as it gets cold and gray falls from the air that you will go on..."

A panelist discusses how effective posttraumatic stress disorder (PTSD) management requires a comprehensive, individualized approach combining evidence-based treatments, ongoing support systems, lifestyle modifications, and regular monitoring of progress while acknowledging that recovery is often a gradual process requiring patience, persistence, and collaboration between health care providers and patients.

A panelist discusses how emerging posttraumatic stress disorder (PTSD) treatments, including psychedelic-assisted therapy, neurofeedback, transcranial magnetic stimulation, and virtual reality exposure protocols, show promising results in clinical trials while offering new hope for treatment-resistant cases.

Celebrating the life of former president Jimmy Carter...

Melanie Barrett, MD; Anita Clayton, MD, and Carmen Kosicek, MSN, PMHNP-BC, discuss how breaking the stigma around postpartum depression requires both healthcare providers and society to normalize open conversations about maternal mental health, while encouraging mothers to seek support without shame or judgment.

Melanie Barrett, MD; Anita Clayton, MD, and Carmen Kosicek, MSN, PMHNP-BC, discuss how real patients navigate the complex journey of seeking and receiving postpartum depression care, from overcoming stigma and recognizing symptoms to finding appropriate healthcare providers and accessing treatment while managing new motherhood responsibilities.

"Things fall apart; the centre cannot hold; Mere anarchy is loosed upon the world..."

A panelist discusses how clinicians implement posttraumatic stress disorder (PTSD) treatments through a carefully structured approach that begins with establishing safety and stabilization, progresses through trauma processing using evidence-based interventions, and concludes with integration and relapse prevention strategies, all while maintaining therapeutic alliance and adjusting treatment intensity based on patient response.

A panelist discusses how treatment options for posttraumatic stress disorder (PTSD) encompass a wide range of evidence-based approaches, including trauma-focused cognitive behavioral therapy, medication management, exposure therapy, and complementary interventions such as mindfulness and group support, which can be tailored to meet individual patient needs and circumstances.

Panelists discuss how the recent FDA-approved treatments for postpartum depression (PPD), including zuranolone and brexanolone , offer new options for rapid symptom relief and improve the management of severe PPD cases.

A panelist discusses how a posttraumatic stress disorder (PTSD) diagnosis in clinical settings requires a comprehensive evaluation process that includes gathering detailed trauma history, assessing current symptoms through validated assessment tools, conducting differential diagnosis to rule out other conditions, and considering cultural and contextual factors that may influence symptom presentation.